Technical Analysis for GBNH - Greenbrook TMS Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.12 | -40.69% | -0.08 |
GBNH closed down 40.69 percent on Friday, February 23, 2024, on 2.21 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 27
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Fell Below 20 DMA | Bearish | -40.69% | |
Fell Below 200 DMA | Bearish | -40.69% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/27/2024
Greenbrook TMS Inc., together with its subsidiaries, operates a network of outpatient mental health services centers in the United States. It offers transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy that provides electromagnetic stimulation to brain regions associated with mood regulation for the treatment of major depressive disorder and other mental health disorders. The company operates approximately 121 treatment centers in the United States. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Sector: Healthcare
Industry: Medical Care Facilities
Keywords: Medicine Neuroscience FDA Medical Device Major Depressive Disorder Neurophysiology Neurotechnology Neuropsychology Treatment Of Major Depressive Disorder Electrotherapy Mental Health Disorders Transcranial Magnetic Stimulation
Classification
Sector: Healthcare
Industry: Medical Care Facilities
Keywords: Medicine Neuroscience FDA Medical Device Major Depressive Disorder Neurophysiology Neurotechnology Neuropsychology Treatment Of Major Depressive Disorder Electrotherapy Mental Health Disorders Transcranial Magnetic Stimulation
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.82 |
52 Week Low | 0.1031 |
Average Volume | 2,690,599 |
200-Day Moving Average | 0.37 |
50-Day Moving Average | 0.27 |
20-Day Moving Average | 0.25 |
10-Day Moving Average | 0.22 |
Average True Range | 0.07 |
RSI (14) | 37.89 |
ADX | 25.17 |
+DI | 41.67 |
-DI | 28.64 |
Chandelier Exit (Long, 3 ATRs) | 0.42 |
Chandelier Exit (Short, 3 ATRs) | 0.32 |
Upper Bollinger Bands | 0.36 |
Lower Bollinger Band | 0.14 |
Percent B (%b) | -0.11 |
BandWidth | 85.26 |
MACD Line | -0.02 |
MACD Signal Line | -0.01 |
MACD Histogram | -0.0078 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.24 | ||||
Resistance 3 (R3) | 0.24 | 0.21 | 0.22 | ||
Resistance 2 (R2) | 0.21 | 0.18 | 0.21 | 0.21 | |
Resistance 1 (R1) | 0.17 | 0.16 | 0.15 | 0.16 | 0.20 |
Pivot Point | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 |
Support 1 (S1) | 0.09 | 0.11 | 0.07 | 0.08 | 0.04 |
Support 2 (S2) | 0.06 | 0.09 | 0.05 | 0.03 | |
Support 3 (S3) | 0.01 | 0.06 | 0.02 | ||
Support 4 (S4) | 0.01 |